ISPOR Europe 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Student Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Media Partners
Exhibitor Directory
Photo Gallery
ISPOR
Europe 2024
17 - 20 November
Home
Events
Past Conferences
ISPOR Europe 2024
Program
Plenary Sessions
Session
The Budget Impact of Venetoclax Plus Obinutuzumab for First-Line Chronic Lymphocytic Leukemia in Saudi Arabia
Nov 20, 2024, 09:00 AM
«
581
582
583
584
585
586
587
588
(current)
589
590
»